These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 667864)

  • 21. Adriamycin and the heart.
    Henderson IC; Frei TE
    N Engl J Med; 1979 Feb; 300(6):310-2. PubMed ID: 759884
    [No Abstract]   [Full Text] [Related]  

  • 22. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?].
    Reinhardt D; Hofmann V; Martz G
    Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxorubicin (Adriamycin) cardiotoxicity.
    Weisburst MR; Pearlman ES; Capone RJ
    Conn Med; 1980 Mar; 44(3):133-6. PubMed ID: 7363615
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention of doxorubicin-induced congestive heart failure by continuous intravenous infusion in multiple myeloma; a case report and review of the literature.
    Lieverse RJ; Ossenkoppele GJ
    Neth J Med; 1991 Feb; 38(1-2):33-4. PubMed ID: 2030807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Echocardiographic evaluation of adriamycin cardiotoxicity during polychemotherapy (author's transl)].
    Christmann D; Bareiss P; Boilletot A; Bergerat JP; Oberling F
    Nouv Rev Fr Hematol (1978); 1981; 23(3):149-54. PubMed ID: 7290990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A possible mechanism for adriamycin induced cardiotoxicity.
    Julka D; Sarin S; Gill KD
    Indian J Exp Biol; 1994 Feb; 32(2):146-8. PubMed ID: 8045615
    [No Abstract]   [Full Text] [Related]  

  • 27. [Non-invasive methods in the monitoring of patients treated with adriamycin].
    Rozo L; Carlier R; Fumoleau P; Nicolas G
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1341-8. PubMed ID: 6797373
    [No Abstract]   [Full Text] [Related]  

  • 28. Adriamycin and mitomycin C: possible synergistic cardiotoxicity.
    Buzdar AU; Legha SS; Tashima CK; Hortobagyi GN; Yap HY; Krutchik AN; Luna MA; Blumenschein GR
    Cancer Treat Rep; 1978 Jul; 62(7):1005-8. PubMed ID: 688243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High fat diet-fed obese rats are highly sensitive to doxorubicin-induced cardiotoxicity.
    Mitra MS; Donthamsetty S; White B; Mehendale HM
    Toxicol Appl Pharmacol; 2008 Sep; 231(3):413-22. PubMed ID: 18674790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin-induced cardiotoxicity.
    Paz-Ares L; Dobbs N; Twelves C
    N Engl J Med; 1995 Nov; 333(20):1360. PubMed ID: 7566044
    [No Abstract]   [Full Text] [Related]  

  • 31. Dosing time dependency of doxorubicin-induced cardiotoxicity and bone marrow toxicity in rats.
    To H; Ohdo S; Shin M; Uchimaru H; Yukawa E; Higuchi S; Fujimura A; Kobayashi E
    J Pharm Pharmacol; 2003 Jun; 55(6):803-10. PubMed ID: 12841941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of adriamycin cardiotoxicity by echocardiography.
    Ewy GA; Jones SE; Groves BM; Gaines JA
    Ariz Med; 1978 Jun; 35(6):402-5. PubMed ID: 687134
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cardiomyopathy due to adriamycin: the possibility of its prevention. Monitoring by noninvasive technics].
    Bianchi L; Bertocchi C; Felci U; Ferrario G; Giani P; Mariani L; Medolago G; Sarti E
    Minerva Med; 1989 Mar; 80(3):215-26. PubMed ID: 2717043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxorubicin-induced cardiotoxicity.
    Silber JH; Barber G
    N Engl J Med; 1995 Nov; 333(20):1359-60. PubMed ID: 7566043
    [No Abstract]   [Full Text] [Related]  

  • 35. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
    Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
    Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin].
    Okuma K; Furuta I; Ota K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):502-8. PubMed ID: 6703724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127).
    Wheeler DM
    Cancer Chemother Rep; 1975; 59(2 Pt 1):258-9. PubMed ID: 1149002
    [No Abstract]   [Full Text] [Related]  

  • 38. Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.
    Chlebowski RT; Paroly WS; Pugh RP; Hueser J; Jacobs EM; Pajak TF; Bateman JR
    Cancer Treat Rep; 1980 Jan; 64(1):47-51. PubMed ID: 7379058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Monitoring cardiotoxicity during antineoplastic chemotherapy].
    Jurga L; Ponist J; Jonás P; Berc A; Misurová E
    Cesk Radiol; 1987 Jan; 41(1):28-37. PubMed ID: 3815581
    [No Abstract]   [Full Text] [Related]  

  • 40. 24-hour mean pulse. Simple predictor of doxorubicin-induced cardiac damage.
    Hrushesky WJ; Vukelich M; Steiner B; Dell I; Mukai K
    Am J Med; 1984 Sep; 77(3):399-406. PubMed ID: 6475981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.